In win for Indivior, US court blocks Dr Reddy's from selling generic drug


A US court has granted Indivior a preliminary injunction blocking India's Dr Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Indivior said on Friday. Indivior, a maker of opioid addiction treatments spun-off from Reckitt Benckiser in 2014, has been involved in a number of legal battles with generic drugmakers over their versions of its Suboxone Film .

Indivior got a temporary restraining order against Dr.Reddy's in.

This article is no longer available in our repository.

There could be multiple reasons for this.